APA (7th ed.) Citation

Wilson, J. R., Garner, E. M., Mashayekhi, M., Hubers, S. A., Ramirez Bustamante, C. E., Kerman, S. J., . . . Brown, N. J. (2022). DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment. Hypertension (Dallas, Tex. 1979), 79(4), 827-835. https://doi.org/10.1161/HYPERTENSIONAHA.121.18348

Chicago Style (17th ed.) Citation

Wilson, Jessica R., Erica M. Garner, Mona Mashayekhi, Scott A. Hubers, Claudia E. Ramirez Bustamante, Scott Jafarian Kerman, Hui Nian, Cyndya A. Shibao, and Nancy J. Brown. "DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment." Hypertension (Dallas, Tex. 1979) 79, no. 4 (2022): 827-835. https://doi.org/10.1161/HYPERTENSIONAHA.121.18348.

MLA (9th ed.) Citation

Wilson, Jessica R., et al. "DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment." Hypertension (Dallas, Tex. 1979), vol. 79, no. 4, 2022, pp. 827-835, https://doi.org/10.1161/HYPERTENSIONAHA.121.18348.